ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Immunotherapy proves effective for the first time as a sole treatment for a subtype of metastatic colorectal cancer

31/05/2020|Comments Off on Immunotherapy proves effective for the first time as a sole treatment for a subtype of metastatic colorectal cancer

ASCO 2020: VHIO researchers contribute to new advances against colorectal cancer

29/05/2020|Comments Off on ASCO 2020: VHIO researchers contribute to new advances against colorectal cancer

Immunotherapy in lung cancer, personalizing melanoma treatment and preventing burnout, at ASCO

29/05/2020|Comments Off on Immunotherapy in lung cancer, personalizing melanoma treatment and preventing burnout, at ASCO

ASCO 2020: VHIO presents new treatments to fight metastatic breast cancer

29/05/2020|Comments Off on ASCO 2020: VHIO presents new treatments to fight metastatic breast cancer

For the first time, a combination of immunotherapy and chemotherapy has been shown to be effective in patients with pancreas cancer

25/05/2020|Comments Off on For the first time, a combination of immunotherapy and chemotherapy has been shown to be effective in patients with pancreas cancer

Researchers close in on Myc inhibition cancer treatment

07/05/2020|Comments Off on Researchers close in on Myc inhibition cancer treatment

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2018

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS